
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
α-internexin CRISPR/Cas9 KO Plasmid (h) | sc-402920 | 20 µg | $397.00 |
INA encodes α-internexin, a neuronal intermediate filament protein that contributes to cytoskeletal architecture and axonal caliber by assembling into filament networks with other neurofilament subunits. It supports neurite outgrowth, axon stability, and intracellular transport by organizing the intermediate filament system within developing and mature neurons. Dysregulation of intermediate filament dynamics, including altered INA expression or filament organization, is frequently examined in the context of neuronal vulnerability, axonopathy, and protein-aggregation–associated neurodegenerative processes. As a neuron-enriched structural protein, α-internexin is widely used as a marker and mechanistic entry point for studies of neuronal differentiation and cytoskeletal remodeling.
α-internexin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the INA gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the INA together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the INA open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish α-internexin protein expression.
This CRISPR knockout system enables efficient generation of INA-deficient cell models for investigation of α-internexin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.